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S U M M A R Y
Introduction: Egypt has the highest reported prevalence of hepatitis C virus (HCV) globally. Until now, no
systematic review has been conducted to understand risk factors associated with these high prevalence
rates of HCV. This study attempted to identify the various HCV risk factors in Egypt responsible for the
high incidence and prevalence rates.
Methods: Using systematic literature review methods, we searched databases for eligible manuscripts,
selecting cohort and case–control studies published in English. Peer-reviewed papers published between
2008 and February 2013 were included. A total of 11 articles met the study selection criteria.
Results: The most examined risk factors found during our review analysis were surgery, transfusion, and
age (64–82% of total articles; n = 11). Multiple risk factors held signiﬁcant association with HCV infection
in the included research.
Conclusions: Based on this review, the main HCV risk factor categories are unsafe medical practices and
familial risk factors. Improving medical safety and encouraging familial education on HCV may help
reduce the incidence of the disease. Most risk factors for HCV transmission in Egypt are healthcare-
associated. Primary prevention of HCV infection remains important to reduce HCV transmission. Further
research should also focus on risk factor dynamics of HCV in Egypt to reduce transmission and HCV
disease burden.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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Hepatitis C virus (HCV) affects over 200 million people, with an
estimated HCV prevalence of 2.2% globally.1 It has been estimated
that HCV accounts for 27% of cirrhosis and 25% of hepatocellular
carcinoma cases worldwide.2 Global and region-speciﬁc estimates
of HCV prevalence vary greatly, but the highest prevalence (15–
20%) has been reported from Egypt.3 The wave of increased HCV-
related morbidity and mortality is likely due to the widespread
availability of injectable therapies and the illicit use of injectable
drugs.2 Major known modes of transmission include intra-familial
transmission, direct blood contact, mother to child, organ
transplant, injectable treatment for schistosomiasis, needle-stick
injuries, medical and dental procedures, injection drug use, and
sharing contaminated materials like razors and shaving kits.4 No
vaccine exists to prevent HCV infection, and while treatment has
improved considerably over the years, therapy is only partially* Corresponding author. Tel.: +1 402 559 4395; fax: +1 402 552 3683.
E-mail address: kmislam@unmc.edu (K.M. Islam).
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license (http://creativecommons.org/licenses/by-nc-nd/3.0/).effective and is plagued by side effects that contribute to treatment
failure. Thus the prevention of primary HCV infection is a public
health issue of major importance.5
While systematic reviews have focused on the prevalence of the
disease in Egypt,6 no systematic review has to date been completed
to understand the risk factors associated with the high prevalence
rates of HCV in Egypt. This review aimed to identify the various risk
factors for HCV in Egypt that are responsible for the high continued
incidence and prevalence rates. The ﬁndings are intended to
inform and shape future research on HCV in Egypt in order to
reduce transmission of the disease by suggesting various inter-
ventions, such as basic prevention procedures, infection control,
screening programs, and raising public awareness to reduce the
burden of the disease to further limit the spread of this infection.
2. Methods
A literature search of PubMed was performed using the
following keywords: Risk Factors for Hepatitis C Egypt. The search
was conducted in February 2013. The ﬁnal analysis included
articles written in English, with a case–control or longitudinalciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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Figure 1. Systematic literature review methods.
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(2008–2012). Additional searches using the same criteria were
performed at the same time in the EBSCO Host and Google Scholar
databases.
The initial search yielded 166 articles from PubMed, 185 from
EBSCO Host, and 6.410 from Google Scholar. After assessing articles
for inclusion and exclusion criteria, as well as removing duplicate
articles, 11 articles were included in the ﬁnal analysis.7–17 Most
studies (72%; n = 8) were cohort studies. The systematic review
methods are shown in Figure 1.
3. Results
The 11 articles included in this systematic review considered a
total 53 possible risk factors for HCV transmission. Approximately
50% of all examined risk factors were studied in more than oneTable 1
The 10 most prevalent risk factors
Risk factor Number of articles included
Surgery 9
Transfusion 8
Age 7
Hospitalization 7
Familial transmission 5
Gender 5
IV 5
Dental procedure 4
Schistosomiasis treatment 3
Mother’s HCV status 3
IV, intravenous injection; HCV, hepatitis C virus.study (50.9%; n = 27). Thirty percent of risk factors were examined
in three or more studies (n = 16). The 10 most prevalent risk factors
are shown in Table 1. The most examined risk factors found during
our review analysis were surgery, transfusion, age, and hospitali-
zation, which were examined in 64–82% of total studies (n = 11).
Familial transmission was examined in ﬁve articles (45%), dental
procedure in four articles (36%), and schistosomiasis treatment and
mother’s HCV status in three articles (27%).
Almost 80% (79.2%; n = 42) of the risk factors assessed were
found to be statistically associated with HCV infection. This may be
an indicator of how complicated HCV transmission in Egypt can be.
The 10 risk factors most often found signiﬁcant are shown in
Table 2.
Surgery, reported to be signiﬁcant in seven of the nine studies in
which it was included, familial transmission (4/5), and intravenousTable 2
The 10 risk factors most often found statistically signiﬁcant
Risk factor Number of articles
found signiﬁcanta
Number of
articles included
Catheter 2 2
Stitches 2 2
Gum treatment 2 2
Illiteracy 3 3
Mother’s HCV status 3 3
Schistosomiasis treatment 3 3
Number of pregnancies 2 2
Familial transmission 4 5
IV 4 5
Surgery 7 9
HCV, hepatitis C virus; IV, intravenous injection.
a Risk factors included in only one article are excluded from the table.
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examined. Other signiﬁcant risk factors included schistosomiasis
treatment (3/3), mother’s HCV status (3/3), illiteracy (3/3), number
of pregnancies (2/2), gum treatment (2/2), stitches (2/2), and
catheter use (2/2). After investigating the risk factors that were
examined but not found statistically signiﬁcant, it appears that the
studies may have seen a small number of newly infected cases,
which may have had some effect on the ﬁndings.9,11,16
4. Discussion
Our review results identiﬁed two major groups of risk factors
for HCV transmission in Egypt: unsafe medical practices and other
risk factors. Medical practice-related factors included surgery, IV
injection, intravenous schistosomiasis treatment, gum disease
treatment, stitches, and catheter use. A majority of routes for HCV
transmission may stem from unsafe medical practices relating to
the treatments listed above.
The other risk factors important for transmission of HCV
included illiteracy, mother’s HCV status, parity, and familial
transmission. Education, especially for mothers, may help reduce
transmission to other family members.
Since limited resources are available for HCV prevention, the
focus should be directed on safe practices in healthcare settings.6
The allocation of ﬁnancial resources is important in strengthening
infection control programs in all healthcare institutions of Egypt.6
Primary prevention is still the best strategy, since between 55% and
85% of patients who acquire acute HCV remain chronically
infected, and 5% to 20% of these patients go on to develop cirrhosis
in 20 to 25 years.1
To prevent nosocomial infection, efforts should be made to
ensure blood donors continue to be screened for HCV, with positive
donors being rejected, thus reducing the risk to patients requiring
transfusions.6 In addition, a policy requiring proper sterilization of
medical and dental instruments should be put in place to reduce
the risk of HCV transmission. Finally, healthcare professionals
should receive training on HCV, with speciﬁc instructions not to
reuse syringes, as well as other techniques to reduce the risk of
transmission.7
The current antiviral regimen is very effective, leading to a
sustained virological response rate close to 100% if treatment starts
early for acute HCV. Unfortunately, most cases of HCV when
diagnosed are chronic HCV, and spontaneous viral clearance is rare
in patients with chronic HCV infection.
In order to reduce the transmission from mother to child, it is
imperative to increase HCV screening in all pregnant women and
to treat them accordingly. Infants born to HCV-positive mothers
should also be screened and treated for HCV as soon as it presents.
Knowledge of the HCV status and treatment of the disease may
help reduce transmission and negative individual health out-
comes.
Further research is needed to understand how intrafamilial
transmission occurs with regard to spouses and children.7 More
attention should be given to intrafamilial HCV transmission.
Considerable awareness should be created regarding the higher
risk of communicability among families with an HCV-infected
member.
Our study included studies published in the English language in
peer-reviewed journals. Any studies published in other languages
and not in peer-reviewed journals were not included in this review.
We acknowledge this limitation of our study. On the other hand,we included only cohort and case–control studies in our review in
order to study the causal relationships between possible risk
factors and HCV infection in Egypt.
In conclusion, the most important risk factors for HCV
transmission in Egypt are healthcare-associated. Other factors
also contribute to the transmission of HCV in the country. Further
research should be carried out to investigate the emerging risks of
transmission.7 Healthcare policy-makers in Egypt and other
developing countries should develop and implement healthcare
quality assurance policies to improve the overall quality of care.
For now, primary prevention of HCV infection remains an
important measure to reduce HCV transmission in resource-
limited countries.
Acknowledgements
We thank Chioma Amadi, Gulnaz Kurbaniyazova, and Messan
Ametitovi, UNMC.
Conﬂict of interest: The authors declare no conﬂicts of interest.
References
1. Bostan N, Mahmood T. An overview about hepatitis C: a devastating virus. Crit
Rev Microbiol 2010;36:91–133.
2. Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol
2007;13:2436.
3. Eassa S, Eissa M, Sharaf SM, Ibrahim MH, Hassanein OM. Prevalence of Hepatitis
C Virus Infection and Evaluation of a Health Education Program in El-Ghar
Village in Zagazig, Egypt. J Egypt Public Health Assoc 2007;82:379–404.
4. Centers for Disease Control and Prevention. Hepatitis C information for health
professionals. Atlanta, GA: CDC; 2011. Available at: http://www.cdc.gov/hepa-
titis/HCV/index.htm (accessed 2013).
5. Centers for Disease Control and Prevention. Morbidity and mortality weekly
report. Atlanta, GA: CDC; 2009. Available at: http://www.cdc.gov/mmwr/
(accessed 2013).
6. Mohamoud YA, Mumtaz GR, Riome S, Miller D, Abu-Raddad LJ. The epidemiol-
ogy of hepatitis C virus in Egypt. BMC Infect Dis 2013;13:288.
7. Kandeel A, Talaat M, Aﬁﬁ S, El-Sayed N, Fadeel MA, Hajjeh R, et al. Case control
study to identify risk factors for acute hepatitis C virus infection in Egypt. BMC
Infect Dis 2012;12:294.
8. Jimenez AP, Eldin NS, Rimlinger F, El-Daly M, El-Hariri H, El-Hoseiny M, et al.
HCV iatrogenic and intrafamilial transmission in Greater Cairo, Egypt. Gut
2010;59:1554–60.
9. Saleh DA, Shebl FM, El-Kamary SS, Magder LS, Allam A, Abdel-Hamid M, et al.
Incidence and risk factors for community-acquired hepatitis C infection from
birth to 5 years of age in rural Egyptian children. Trans R Soc Trop Med Hyg
2010;104:357–63.
10. AbdulQawi K, Youssef A, Metwally MA, Ragih I, AbdulHamid M, Shaheen A.
Prospective study of prevalence and risk factors for hepatitis C in pregnant
Egyptian women and its transmission to their infants. Croat Med J
2010;51:219–28.
11. Mostafa A, Taylor SM, El-Daly M, El Hoseiny M, Bakr I, Arafa N, et al. Is the
hepatitis C virus epidemic over in Egypt?. Incidence and risk factors of new
hepatitis C virus infections. Liver Int 2010;30:560–6.
12. Doa’a AS, Shebl F, Abdel-Hamid M, Narooz S, Mikhail N, El-Batanony M, et al.
Incidence and risk factors for hepatitis C infection in a cohort of women in rural
Egypt. Trans R Soc Trop Med Hyg 2008;102:921–8.
13. Plancoulaine S, Mohamed MK, Arafa N, Bakr I, Rekacewicz C, Tre´goue¨t DA, et al.
Dissection of familial correlations in hepatitis C virus (HCV) seroprevalence
suggests intrafamilial viral transmission and genetic predisposition to infec-
tion. Gut 2008;57:1268–74.
14. Esmat G, Hashem M, El-Raziky M, El-Akel W, El-Naghy S, El-Koofy N, et al. Risk
factors for hepatitis C virus acquisition and predictors of persistence among
Egyptian children. Liver Int 2012;32:449–56.
15. Zahran KM, Badary MS, Agban MN, Abdel Aziz NH. Pattern of hepatitis virus
infection among pregnant women and their newborns at the Women’s Health
Center of Assiut University, Upper Egypt. Int J Gynecol Obstet 2010;111:171–4.
16. Shebl FM, El-Kamary SS, Saleh DA, Abdel-Hamid M, Mikhail N, Allam A, et al.
Prospective cohort study of mother-to-infant infection and clearance of hepa-
titis C in rural Egyptian villages. J Med Virol 2009;81:1024–31.
17. Jimenez AP, Mohamed MK, Eldin NS, Seif HA, El Aidi S, Sultan Y, et al. Injection
drug use is a risk factor for HCV infection in urban Egypt. PLoS One
2009;4:e7193.
